Vol. 18/No. 12 | OncologyLive

Evolving Neoadjuvant and Adjuvant Therapeutic Approaches in RCC

June 16, 2017

Surgical resection, including cytoreductive nephrectomy, remains the standard of care for most patients with renal cell carcinoma, but many patients will have a recurrence, and could benefit from additional therapy.

Hidden Baseline Clinical Factors Often Influence Study Results

June 08, 2017

There is an intense and seemingly growing debate within the clinical, research, and regulatory arenas regarding what should be appropriately required to declare that a new or novel strategy be considered an acceptable standard-of-care approach to cancer management within a particular setting.